Evidence map›Paper›PMID 35720336›Full record

ArticleFrontiers in immunology2022

Clinical Variables, Deep Learning and Radiomics Features Help Predict the Prognosis of Adult Anti-N-methyl-D-aspartate Receptor Encephalitis Early: A Two-Center Study in Southwest China.

Yayun Xiang, Xiaoxuan Dong, Chun Zeng, Junhang Liu, Hanjing Liu, Xiaofei Hu, Jinzhou Feng, Silin Du, Jingjie Wang, Yongliang Han and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yayun XiangDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Xiaoxuan DongCollege of Computer and Information Science, Chongqing, China.
Chun ZengDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Junhang LiuDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Hanjing LiuDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Xiaofei HuDepartment of Neurology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Jinzhou FengDepartment of Neurology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Silin DuDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Jingjie WangDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Yongliang HanDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Qi LuoDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Shanxiong ChenCollege of Computer and Information Science, Chongqing, China.
Yongmei LiDepartment of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop a fusion model combining clinical variables, deep learning (DL), and radiomics features to predict the functional outcomes early in patients with adult anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in Southwest China. Methods: From January 2012, a two-center study of anti-NMDAR encephalitis was initiated to collect clinical and MRI data from acute patients in Southwest China. Two experienced neurologists independently assessed the patients' prognosis at 24 moths based on the modified Rankin Scale (mRS) (good outcome defined as mRS 0-2; bad outcome defined as mRS 3-6). Risk factors influencing the prognosis of patients with acute anti-NMDAR encephalitis were investigated using clinical data. Five DL and radiomics models trained with four single or combined four MRI sequences (T1-weighted imaging, T2-weighted imaging, fluid-attenuated inversion recovery imaging and diffusion weighted imaging) and a clinical model were developed to predict the prognosis of anti-NMDAR encephalitis. A fusion model combing a clinical model and two machine learning-based models was built. The performances of the fusion model, clinical model, DL-based models and radiomics-based models were compared using the area under the receiver operating characteristic curve (AUC) and accuracy and then assessed by paired t-tests ( Results: The fusion model achieved the significantly greatest predictive performance in the internal test dataset with an AUC of 0.963 [95% CI: (0.874-0.999)], and also significantly exhibited an equally good performance in the external validation dataset, with an AUC of 0.927 [95% CI: (0.688-0.975)]. The radiomics_combined model (AUC: 0.889; accuracy: 0.857) provided significantly superior predictive performance than the DL_combined (AUC: 0.845; accuracy: 0.857) and clinical models (AUC: 0.840; accuracy: 0.905), whereas the clinical model showed significantly higher accuracy. Compared with all single-sequence models, the DL_combined model and the radiomics_combined model had significantly greater AUCs and accuracies. Conclusions: The fusion model combining clinical variables and machine learning-based models may have early predictive value for poor outcomes associated with anti-NMDAR encephalitis.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisDeep LearningHumansMagnetic Resonance ImagingPrognosisRetrospective Studiesanti-N-methyl-D-aspartate receptorautoimmune encephalitisclinical featuresdeep learningmultiparametric MRI (mpMRI)predictorprognosisradiomics

Identifiers

PMID35720336
PMCPMC9199424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.